Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ)
CNY 6.24
(-0.79%)
CNY 6.24
(-0.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 737.81 Million | 797.64 Million | 837.1 Million | 688.16 Million | 731.34 Million | 843.83 Million |
| Cost of Revenue | 549.88 Million | 502.52 Million | 535.86 Million | 408.53 Million | 391.54 Million | 364.35 Million |
| Gross Profit | 187.93 Million | 295.11 Million | 301.24 Million | 279.63 Million | 339.79 Million | 479.47 Million |
| Operating Expenses | 343.25 Million | 208.98 Million | 185.38 Million | 172.61 Million | 203.29 Million | 227.96 Million |
| Selling, General and Administrative Expenses | 112.73 Million | 77.99 Million | 75.85 Million | 79.99 Million | 107.21 Million | 90.02 Million |
| Research and Development Expenses | 74.75 Million | 68.97 Million | 52.06 Million | 38.77 Million | 53.77 Million | 64.68 Million |
| Other Expenses | 59.27 Million | 62 Million | 57.46 Million | 53.84 Million | 42.3 Million | -4.07 Million |
| Cost and Expenses | 878.87 Million | 711.51 Million | 721.24 Million | 581.15 Million | 594.83 Million | 592.31 Million |
| Operating Income | -141.05 Million | 97.62 Million | 118.19 Million | 96.83 Million | 136.96 Million | 211.14 Million |
| Interest Expense | 49.15 Million | 21.1 Million | 16.68 Million | 32.61 Million | 35.11 Million | 30.69 Million |
| Income Tax Expense | 11.74 Million | 12.36 Million | 18.53 Million | 17.84 Million | 16.71 Million | 33.65 Million |
| Earnings before Tax | -140.66 Million | 60.08 Million | 124.33 Million | 88.14 Million | 99.89 Million | 207.06 Million |
| Net Income | -140.24 Million | 50.33 Million | 110.1 Million | 74.64 Million | 86.94 Million | 171.72 Million |
| Earnings Per Share Basic | -0.40 | 0.15 | 0.32 | 0.22 | 0.29 | 0.58 |
| Earnings Per Share Diluted | -0.39 | 0.14 | 0.32 | 0.22 | 0.29 | 0.57 |
| Weighted Average Shares Outstanding | 353.98 Million | 343.99 Million | 343.97 Million | 334.44 Million | 298.45 Million | 298.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 355.77 Million | 352.7 Million | 343.97 Million | 334.44 Million | 298.45 Million | 302.16 Million |
| Gross Margin | 0.25 | 0.37 | 0.36 | 0.41 | 0.46 | 0.57 |
| EBIT Margin | -0.00 | 0.25 | 0.28 | 0.31 | 0.30 | 0.39 |
| Profit Margin | -0.19 | 0.06 | 0.13 | 0.11 | 0.12 | 0.20 |
| EBITDA | -2.67 Million | 179.49 Million | 215.47 Million | 216.52 Million | 220.97 Million | 320.57 Million |
| Earnings Before Tax Margin | -0.19 | 0.12 | 0.14 | 0.14 | 0.19 | 0.25 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 162.34 Million | 116.29 Million | 180.16 Million | 215.32 Million | 737.81 Million | 178.58 Million |
| Cost of Revenue | 133.79 Million | 71.4 Million | 150.66 Million | 163.76 Million | 535.62 Million | 133.88 Million |
| Gross Profit | 28.55 Million | 44.88 Million | 29.49 Million | 51.56 Million | 202.19 Million | 44.69 Million |
| Operating Expenses | 73.84 Million | 74.77 Million | 74.6 Million | 86.73 Million | 275.41 Million | 73.05 Million |
| Selling, General and Administrative Expenses | 55.4 Million | 11.68 Million | 60.65 Million | -20.71 Million | - | 93.69 Million |
| Research and Development Expenses | 16.28 Million | 12.32 Million | 16.09 Million | 25.81 Million | - | 21.8 Million |
| Other Expenses | -18.43 Million | 52.67 Thousand | 981.73 Thousand | 186.83 Thousand | 386.68 Thousand | 832.26 Thousand |
| Cost and Expenses | 207.63 Million | 146.17 Million | 225.27 Million | 250.49 Million | 811.03 Million | 206.94 Million |
| Operating Income | -45.28 Million | -59.87 Million | -56.18 Million | -67.63 Million | -141.05 Million | -45.42 Million |
| Interest Expense | 14.92 Million | 19.81 Million | 9.33 Million | 17.22 Million | 49.15 Million | 16.62 Million |
| Income Tax Expense | 917.32 Thousand | 1.07 Million | -535 Thousand | 13.17 Million | 11.74 Million | -922.4 Thousand |
| Earnings before Tax | -55.34 Million | -59.81 Million | -55.2 Million | -67.44 Million | -140.66 Million | -44.59 Million |
| Net Income | -51.93 Million | -56.13 Million | -50.5 Million | -73.27 Million | -140.24 Million | -41.17 Million |
| Earnings Per Share Basic | -0.15 | -0.16 | -0.14 | -0.21 | - | -0.12 |
| Earnings Per Share Diluted | -0.15 | -0.16 | -0.14 | -0.21 | - | -0.12 |
| Weighted Average Shares Outstanding | 343.99 Million | 353.94 Million | 353.94 Million | 348.79 Million | 353.98 Million | 343.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 343.99 Million | 353.94 Million | 353.94 Million | 349.69 Million | 355.77 Million | 343.6 Million |
| Gross Margin | 0.18 | 0.39 | 0.16 | 0.24 | 0.27 | 0.25 |
| EBIT Margin | -0.25 | -0.25 | -0.24 | -0.17 | - | -0.16 |
| Profit Margin | -0.32 | -0.48 | -0.28 | -0.34 | -0.19 | -0.23 |
| EBITDA | -40.41 Million | -28.67 Million | -43.96 Million | -37.2 Million | - | -28.31 Million |
| Earnings Before Tax Margin | -0.28 | -0.51 | -0.31 | -0.31 | -0.19 | -0.25 |
NEXI
TAM
KONYA
605333
GOKAKTEX
JIAXF